Fiducial Markers Market, By Product (CT/CBCT, MRI, X-ray/Fluoroscopy, Hybrid MRI-LINAC System, and Ultrasound), By Modality, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5198
|
Published Date
May 2026
|
Pages
382
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Fiducial Markers Market size was valued at US$ 190.71 Million in 2025, expanding at a CAGR of 8.09% from 2026 to 2033.
Fiducial markers are small medical devices or reference points placed inside or on the body to identify specific locations, typically tumors or treatment sites. They are clearly visible on imaging modalities such as X-rays, CT scans, or MRI, enabling clinicians to accurately locate and target areas for diagnosis and treatment. The fiducial markers market is gradually expanding alongside advancements in cancer treatment and medical imaging technologies, as healthcare systems increasingly prioritize precision, safety, and treatment accuracy.
From a broader perspective, the World Health Organization (WHO) continues to emphasize the growing global burden of cancer and encourages countries to strengthen their diagnostic and treatment capabilities, including the adoption of precise targeting techniques. In addition, advancements in radiation therapy across regions such as North America and Europe are further supporting the use of image-guided procedures. Industry standards developed by organizations such as the National Electrical Manufacturers Association (NEMA), including DICOM imaging standards, also facilitate consistent and interoperable medical imaging workflows. Collectively, these factors are contributing to the rising adoption of fiducial markers in precision-based cancer treatment.
Fiducial Markers Market- Market Dynamics
Growing emphasis on precision-based cancer treatment is driving the need for more accurate and targeted care delivery.
The growing emphasis on precise and targeted cancer treatment is driving increased use of fiducial markers in clinical practice. According to the National Cancer Institute and other healthcare organizations, image-guided radiation therapy enables more accurate delivery of radiation while minimizing exposure to surrounding healthy tissue. This approach relies on stable reference points, which are provided by fiducial markers to improve tumor localization during treatment.
In addition, the World Health Organization highlights the continued rise in global cancer incidence, prompting healthcare systems to enhance both treatment quality and patient safety. From an industry perspective, companies such as Boston Scientific have developed gold fiducial markers that help clinicians accurately identify tumor locations during radiotherapy procedures. These advancements reflect a broader shift toward precision-based oncology, where accurate targeting and improved treatment outcomes are becoming central priorities in cancer care.
Fiducial Markers Market- Segmentation Analysis:
The Global Fiducial Markers Market is segmented on the basis of Product, Modality, Application, End User, and Region.
The fiducial marker market is segmented by product into metal-based markers, polymer-based markers, bio-absorbable markers, and others. Among these, metal-based markers are expected to account for a significant share due to their strong imaging visibility and clinical reliability across a range of procedures. Typically made of gold or platinum, these markers provide excellent contrast in imaging modalities such as CT scans, X-rays, and MRI. For instance, Boston Scientific offers platinum-based fiducial markers designed to improve visibility across multiple imaging platforms, supporting more precise radiation delivery. Clinically, studies published in medical literature indicate that gold markers provide high imaging contrast, enabling accurate tumor localization, although they may cause minor artifacts in certain imaging techniques. Their structural stability and long-term retention in tissue further enhance positioning reliability, making them a preferred option in many radiotherapy workflows where precision is essential.
By modality, the fiducial marker market is segmented into CT/CBCT, MRI, X-ray/fluoroscopy, hybrid MRI-LINAC systems, and ultrasound. CT/CBCT (Computed Tomography/Cone Beam CT) represents a key segment due to its strong compatibility with radiotherapy workflows and consistent imaging clarity. Clinical studies show that fiducial markers are clearly visible in CT and CBCT imaging and are routinely used for accurate tumor localization and daily treatment alignment in image-guided radiotherapy. From a practical standpoint, CT/CBCT systems are often integrated directly into radiotherapy equipment, allowing clinicians to verify tumor positioning before and during treatment without requiring additional complex procedures. This integration supports efficient workflow and frequent use in hospitals and cancer centers. Additionally, CBCT provides real-time imaging guidance with relatively lower radiation exposure, making it a preferred modality in clinical practice. These factors collectively support the widespread adoption of CT/CBCT-based procedures in fiducial marker applications.
Fiducial Markers Market- Geographical Insights
From a geographical perspective, North America holds a significant share of the fiducial markers market and continues to witness steady adoption, supported by strong public health programs and established reimbursement frameworks. For instance, government organizations such as the National Institutes of Health (NIH) have funded extensive cancer research and advancements in radiotherapy techniques, contributing to the wider use of precision-based treatment tools like fiducial markers. In Europe, healthcare systems collectively manage millions of new cancer cases annually, driving continuous improvements in oncology infrastructure and increasing the adoption of image-guided treatment technologies.
Alongside North America, the Asia-Pacific region is expected to register notable growth due to expanding cancer care capacity and rising patient demand. According to the World Health Organization (WHO), a large proportion of cancer patients require radiotherapy, although access remains limited in several emerging markets. Studies indicate that the region accounts for millions of new cancer cases annually, with rapidly increasing demand for radiotherapy services and equipment. Governments in countries such as China and India are investing in the expansion of radiotherapy infrastructure and improving access to advanced medical technologies. At the same time, healthcare providers and industry players are increasingly introducing oncology solutions to meet this growing demand. These combined efforts are supporting the broader adoption of precision-guided tools and the integration of fiducial markers in modern cancer treatment workflows.
South Korea Fiducial Markers Market- Country Insights
South Korea’s fiducial markers market is shaped by its well-structured cancer care system and sustained public investment in advanced treatment technologies. The Ministry of Health and Welfare supports national cancer control programs that emphasize early diagnosis and precise treatment planning. According to the National Cancer Center Korea, cancer remains one of the most commonly diagnosed health conditions in the country, prompting hospitals to adopt more precise and image-guided treatment approaches. In addition, South Korea has a strong base of radiotherapy and medical imaging infrastructure, which supports the use of guidance tools such as fiducial markers during treatment procedures. Government-backed health insurance coverage further improves access to advanced oncology services, enabling clinicians to more consistently integrate precision-based techniques into routine cancer care.
Fiducial Markers Market- Competitive Landscape:
The competitive landscape of the fiducial markers market is characterized by the presence of established medical technology companies alongside specialized innovators, all focused on improving clinical accuracy, imaging compatibility, and patient-specific treatment precision. Companies such as Boston Scientific, Medtronic, CIVCO Radiotherapy, and Nanovi A/S contribute through a diverse range of products and strategic collaborations. Their key priorities include enhancing marker visibility, ensuring compatibility with multiple imaging modalities, improving ease of placement, and strengthening distribution networks across hospitals and specialized clinics.
Market participants are increasingly emphasizing innovation, clinical partnerships, and the integration of advanced imaging technologies to enhance procedural precision and treatment outcomes. For example, in June 2025, Nanovi A/S advanced the clinical application of its BioXmark liquid fiducial marker, improving adaptability in tumor localization and radiotherapy planning. Companies are also expanding research activities and service networks to better align with the requirements of precision medicine. These strategies are supporting broader adoption and improving the effectiveness of image-guided cancer treatments.
Recent Developments:
- In April 2026, QFIX expanded its radiotherapy positioning and guidance solutions, supporting integration with fiducial marker-based workflows to improve setup accuracy in clinical environments. This enhancement enables more precise treatment alignment, improving targeting consistency and contributing to safer and more efficient radiotherapy procedures.
- In March 2026, Eckert & Ziegler strengthened its oncology portfolio by expanding radiotherapy-related product offerings, including components used in precision targeting solutions such as fiducial markers. This development reflects a continued focus on precision oncology, supporting improved treatment accuracy and aligning product portfolios with evolving radiotherapy practices.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL FIDUCIAL MARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- CIVCO Radiotherapy
- IZI Medical Products
- Boston Scientific Corporation
- Medtronic plc
- Nanovi A/S
- Naslund Medical AB
- QlRad Inc.
- IBA Dosimetry GmbH
- Best Medical International
- Carbon Medical Technologies
- Beekley Medical
- Stellar Medical
- Varian Medical Systems
- AngioDynamics
- RaySearch Laboratories
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Metal-Based Markers
- Polymer-Based Markers
- Bio-Absorbable Markers
- Liquid-Based Markers
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY MODALITY- MARKET ANALYSIS, 2020 - 2033
- CT/CBCT
- MRI
- X-ray/Fluoroscopy
- Hybrid MRI-LINAC System
- Ultrasound
GLOBAL FIDUCIAL MARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 – 2033
- Prostate Cancer
- Lung Cancer
- Breast Cancer
- Liver and Pancreatic Cancer
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Cancer Specialty Centers
- Ambulatory Radiotherapy Clinics
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Fiducial Markers Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Fiducial Markers Market Snippet by Product
2.1.2. Fiducial Markers Market Snippet by Modality
2.1.3. Fiducial Markers Market Snippet by Application
2.1.4. Fiducial Markers Market Snippet by End User
2.1.5. Fiducial Markers Market Snippet by Country
2.1.6. Fiducial Markers Market Snippet by Region
2.2. Competitive Insights
3. Fiducial Markers Key Market Trends
3.1. Fiducial Markers Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Fiducial Markers Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Fiducial Markers Market Opportunities
3.4. Fiducial Markers Market Future Trends
4. Fiducial Markers Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Fiducial Markers Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Fiducial Markers Market Landscape
6.1. Fiducial Markers Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Fiducial Markers Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
7.1.2. Metal-Based Markers
7.1.3. Polymer-Based Markers
7.1.4. Bio-Absorbable Markers
7.1.5. Liquid-Based Markers
7.1.6. Others
8. Fiducial Markers Market – By Modality
8.1. Overview
8.1.1. Segment Share Analysis, By Modality, 2025 & 2033 (%)
8.1.2. CT/CBCT
8.1.3. MRI
8.1.4. X-ray/Fluoroscopy
8.1.5. Hybrid MRI-LINAC System
8.1.6. Ultrasound
9. Fiducial Markers Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
9.1.2. Prostate Cancer
9.1.3. Lung Cancer
9.1.4. Breast Cancer
9.1.5. Liver and Pancreatic Cancer
9.1.6. Others
10. Fiducial Markers Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Modality, 2025 & 2033 (%)
10.1.2. Hospitals
10.1.3. Cancer Specialty Centers
10.1.4. Ambulatory Radiotherapy Clinics
11. Fiducial Markers Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Fiducial Markers Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Fiducial Markers Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Fiducial Markers Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Fiducial Markers Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Fiducial Markers Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Fiducial Markers Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. CIVCO Radiotherapy
12.2.2. IZI Medical Products
12.2.3. Boston Scientific Corporation
12.2.4. Medtronic plc
12.2.5. Nanovi A/S
12.2.6. Naslund Medical AB
12.2.7. QlRad Inc.
12.2.8. IBA Dosimetry GmbH
12.2.9. Best Medical International
12.2.10. Carbon Medical Technologies
12.2.11. Beekley Medical
12.2.12. Stellar Medical
12.2.13. Varian Medical Systems
12.2.14. AngioDynamics
12.2.15. RaySearch Laboratories
12.2.16. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL FIDUCIAL MARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- CIVCO Radiotherapy
- IZI Medical Products
- Boston Scientific Corporation
- Medtronic plc
- Nanovi A/S
- Naslund Medical AB
- QlRad Inc.
- IBA Dosimetry GmbH
- Best Medical International
- Carbon Medical Technologies
- Beekley Medical
- Stellar Medical
- Varian Medical Systems
- AngioDynamics
- RaySearch Laboratories
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Metal-Based Markers
- Polymer-Based Markers
- Bio-Absorbable Markers
- Liquid-Based Markers
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY MODALITY- MARKET ANALYSIS, 2020 - 2033
- CT/CBCT
- MRI
- X-ray/Fluoroscopy
- Hybrid MRI-LINAC System
- Ultrasound
GLOBAL FIDUCIAL MARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 – 2033
- Prostate Cancer
- Lung Cancer
- Breast Cancer
- Liver and Pancreatic Cancer
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Cancer Specialty Centers
- Ambulatory Radiotherapy Clinics
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
